Emory University Hospital — Atlanta, Georgia

Public research footprint of Emory University Hospital, compiled from the ClinicalTrials.gov public registry.

1,390

Registered studies

517

Active

262

Recruiting now

664

Completed

176

Stopped or withdrawn

Most-studied conditions

Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · Anatomic Stage II Breast Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04858334 — APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Emory University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.